Loading…
Lobbying Spend
—
Filings
56
Firms Hired
1
Active Period
2012–2025
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
2017 · fourth_quarter · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Client expense: — · Firm income: $10,000
Matched citations: H.R.1576
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
2017 · third_quarter · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Client expense: — · Firm income: —
Matched citations: H.R.1576
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
2017 · second_quarter · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Client expense: — · Firm income: $70,000
Matched citations: H.R.1576
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
2017 · first_quarter · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Client expense: — · Firm income: $40,000
Matched citations: H.R.1576
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
2016 · fourth_quarter · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Client expense: — · Firm income: $30,000
Matched citations: H.R.1576
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
2016 · third_quarter · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Client expense: — · Firm income: —
Matched citations: H.R.1576
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
2016 · second_quarter · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Client expense: — · Firm income: $40,000
Matched citations: H.R.1576
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
2016 · first_quarter · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Client expense: — · Firm income: —
Matched citations: H.R.1576
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
2015 · fourth_quarter · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Client expense: — · Firm income: $40,000
Matched citations: H.R.1576
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
2015 · third_quarter · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Client expense: — · Firm income: $60,000
Matched citations: H.R.1576
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
2015 · second_quarter · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Client expense: — · Firm income: $70,000
Matched citations: H.R.1576
Source: Senate LDA